Biomedical Engineering Reference
In-Depth Information
fascicularis
as revealed by positron emission tomography and magnetic resonance imaging.
Archives of Toxicology 66: 403-407.
[62]
Hussain SM, AK Javorina, AM Schrand, HM Duhart, SF Ali and JJ Schlager (2006). The inter-
action of manganese nanoparticles with PC-12 cells induces dopamine depletion. Toxicology
Science 92: 456-463.
[63]
Misselwitz B, A Muhler and HJ Weinmann (1995). A toxicologic risk for using manganese
complexes? A literature survey of existing data through several medical specialties. Investigative
Radiology 30: 611-620.
[64]
Hussain SM, KL Hess, JM Gearhart, KT Geiss and JJ Schlager (2005).
In vitro
toxicity of
nanoparticles in BRL 3A rat liver cells. Toxicology
In vitro
19: 975-83.
[65]
Na HB, JH Lee, K An, YI Park, M Park, IS Lee, DH Nam, ST Kim, SH Kim, SW Kim,
et al
.
(2007). Development of a T1 contrast agent for magnetic resonance imaging using MnO
nanoparticles. Angewandte Chemie International Edition English 46: 5397-5401.
[66]
Gilad AA, P Walczak, MT McMahon, HB Na, JH Lee, K An, T Hyeon, PC van Zijl and
JW Bulte (2008). MR tracking of transplanted cells with “positive contrast” using manganese
oxide nanoparticles. Magnetic Resonance in Medicine 60: 1-7.
[67]
Kim T, E Momin, J Choi, K Yuan, H Zaidi, J Kim, M Park, N Lee, MT McMahon, A Quinones-
Hinojosa,
et al
. (2011). Mesoporous silica-coated hollow manganese oxide nanoparticles as
positive T1 contrast agents for labeling and MRI tracking of adipose-derived mesenchymal stem
cells. Journal of the American Chemical Society 133: 2955-2961.
[68]
Bulte JW (2005). Hot spot MRI emerges from the background. Nature Biotechnology 23:
945-946.
[69]
Srinivas M, A Heerschap, ET Ahrens, CG Figdor and IJ de Vries (2010) (19)F MRI for
quantitative
in vivo
cell tracking. Trends Biotechnology 28: 363-370.
[70]
Ruiz-Cabello J, BP Barnett, PA Bottomley and JW Bulte (2011). Fluorine (19 F) MRS and MRI
in biomedicine. NMR in Biomedicine 24: 114-129.
[71]
Haszeldine RN (1951). Synthesis of fluorocarbons, perfluoroalkyl iodides, bromides and chlorides,
and perfluoroalkyl grignard reagents. Nature 167: 139-140.
[72]
Long DM, MS Liu, PS Szanto and P Alrenga (1972). Initial observations with a new x-ray contrast
agent - radiopaque perfluorocarbon. Reviews in Surgery 29: 71-76.
[73]
Tremper KK, R Lapin, E Levine, A Friedman and WC Shoemaker (1980). Hemodynamic and
oxygen transport effects of a perfluorochemical blood substitute, fluosol-DA (20%). Critical
Care Medicine 8: 738-741.
[74]
Ahrens ET, R Flores, H Xu and PA Morel (2005).
In vivo
imaging platform for tracking immu-
notherapeutic cells. Nature Biotechnology 23: 983-987.
[75]
Barnett BP, J Ruiz-Cabello, P Hota, R Ouwerkerk, MJ Shamblott, C Lauzon, P Walczak,
WD Gilson, VP Chacko, DL Kraitchman,
et al
. (2011). Use of perfluorocarbon nanoparticles
for non-invasive multimodal cell tracking of human pancreatic islets. Contrast Media Molecular
Imaging 6: 251-259.
[76]
Boehm-Sturm P, L Mengler, S Wecker, M Hoehn and T Kallur (2011).
In vivo
tracking of human
neural stem cells with 19 F magnetic resonance imaging. PLoS One 6: e29040.
[77]
Ruiz-Cabello J, P Walczak, DA Kedziorek, VP Chacko, AH Schmieder, SA Wickline, GM Lanza
and JW Bulte (2008).
In vivo
“hot spot” MR imaging of neural stem cells using fluorinated
nanoparticles. Magnetic Resonance in Medicine 60: 1506-1511.
[78]
Chen J, GM Lanza and SA Wickline (2010). Quantitative magnetic resonance fluorine imaging:
today and tomorrow. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology
2: 431-440.
[79]
Partlow KC, J Chen, JA Brant, AM Neubauer, TE Meyerrose, MH Creer, JA Nolta,
SD Caruthers, GM Lanza and SA Wickline (2007). 19 F magnetic resonance imaging for stem/
progenitor cell tracking with multiple unique perfluorocarbon nanobeacons. FASEB Journal
21: 1647-1654.
[80]
Ali MM, B Yoo and MD Pagel (2009). Tracking the relative
in vivo
pharmacokinetics of
nanoparticles with PARACEST MRI. Molecular Pharmacology 6: 1409-1416.
[81]
Ferrauto G, D Delli Castelli, E Terreno and S Aime (2013).
In vivo
MRI visualization of different
cell populations labeled with PARACEST agents. Magnetic Resonance in Medicine 69: 1703-11.
